001453466 000__ 03748cam\a2200457\a\4500
001453466 001__ 1453466
001453466 003__ OCoLC
001453466 005__ 20230314003352.0
001453466 006__ m\\\\\o\\d\\\\\\\\
001453466 007__ cr\un\nnnunnun
001453466 008__ 221205s2023\\\\si\\\\\\o\\\\\000\0\eng\d
001453466 020__ $$a9789811956423$$q(electronic bk.)
001453466 020__ $$a9811956421$$q(electronic bk.)
001453466 020__ $$z9811956413
001453466 020__ $$z9789811956416
001453466 0247_ $$a10.1007/978-981-19-5642-3$$2doi
001453466 035__ $$aSP(OCoLC)1353101521
001453466 040__ $$aYDX$$beng$$cYDX$$dGW5XE$$dEBLCP$$dOCLCF$$dOCLCQ$$dN$T
001453466 049__ $$aISEA
001453466 050_4 $$aRC669
001453466 08204 $$a616.1042$$223/eng/20221208
001453466 24500 $$aGenome editing in cardiovascular and metabolic diseases/$$cJunjie Xiao, editor.
001453466 260__ $$aSingapore :$$bSpringer,$$c2023.
001453466 300__ $$a1 online resource.
001453466 4901_ $$aAdvances in experimental medicine and biology ;$$vv. 1396
001453466 5050_ $$aAn overview of genome editing in cardiovascular and metabolic diseases -- Bioinformatics research methodology of genome editing in cardiovascular and metabolic diseases -- Online databases of genome editing in cardiovascular and metabolic diseases -- Application of systems biology for genome editing involved in regulating of cardiovascular and metabolic diseases -- Bioinformatics for reducing off-targets in cardiovascular and metabolic diseases -- Genome editing and cardiac regeneration -- Genome editing and myocardial development -- Genome editing and heart failure -- Genome editing and pathological cardiac hypertrophy -- Genome editing and cardiac remodeling -- Genome editing and diabetic cardiomyopathy -- Genome editing and cardiac arrhythmias -- Genome editing and atrial fibrillation -- Genome editing and muscle atrophy -- Genome editing and obesity -- Genome editing and fatty liver -- Genome editing and diabetes -- Genome editing and gout -- Genome editing and protein energy malnutrition -- Genome therapy and cardiovascular diseases -- Therapeutics in metabolic diseases -- Gene editing and human iPSCs in cardiovascular and editing diseases -- Prospective advances in genome editing investigation.
001453466 506__ $$aAccess limited to authorized users.
001453466 520__ $$aThis book provides the latest research progress on genome editing in cardiovascular and metabolic diseases and includes bioinformatics research methodology of genome editing. Genome editing is a genetic engineering technique precisely modified specific target genes of organism genome, which has been applied to basic theoretical research and production applications from plants and animals to gene therapy of human beings. Cardiovascular and metabolic diseases have become major factors affecting human health worldwide. This book contains information about bioinformatics, genome editing in cardiovascular diseases, genome editing in metabolic diseases and therapeutic effects. It will be useful for biologist, cardiologist, cardiovascular surgeons, endocrinologist, internists, nurses, undergraduate and graduate students in medicine and cell biology and others interested in cardiovascular and metabolic medicine.
001453466 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed December 8, 2022).
001453466 650_0 $$aCardiovascular system$$xDiseases$$xGenetic aspects.
001453466 650_0 $$aGene editing.
001453466 655_0 $$aElectronic books.
001453466 7001_ $$aXiao, Junjie,$$d1983-$$eeditor.
001453466 77608 $$iPrint version:$$z9811956413$$z9789811956416$$w(OCoLC)1335112615
001453466 830_0 $$aAdvances in experimental medicine and biology ;$$vv. 1396.
001453466 852__ $$bebk
001453466 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-5642-3$$zOnline Access$$91397441.1
001453466 909CO $$ooai:library.usi.edu:1453466$$pGLOBAL_SET
001453466 980__ $$aBIB
001453466 980__ $$aEBOOK
001453466 982__ $$aEbook
001453466 983__ $$aOnline
001453466 994__ $$a92$$bISE